📢 POLY-HF: Daily Polypill Boosts Heart Function, QOL, and Cuts Hospitalizations in Underserved Patients With #HFrEF Read more: https://bit.ly/4hV9byv #AHA25 #HeartFailure #CardioSky #MedSky

FOOD-HF shows promise: Food-as-Medicine improved QoL post-#HeartFailure discharge, though HF events remained unchanged. Details from #AHA25: https://bit.ly/47QjFKE #CardioSky #MedSky

Early Initiation of PSCK9 inhibition with alirocumab ➕ statin therapy safely lowered LDL-C in #Hearttx patients, but didn’t ⬇️ coronary artery plaque progression, based on CAVIAR findings presented at #AHA25. Read more: https://bit.ly/444cwVZ #HeartFailure #CardioSky #MedSky

Stress CMR-guided #cvImaging in patients w/ chest pain & nonobstructive #cvCAD was superior to angiography only in correctly diagnosing microvascular angina & improving chest pain symptoms & QoL, based on findings from CorCMR trial presented at #AHA25. 🔗 https://bit.ly/4hRZ0dJ

TUXEDO-2 findings suggest a ticagrelor-based #DAPT regimen does not offer the same level of benefit at preventing heart attack, stroke, bleeding complications or death as a prasugrel-based regimen. Read more as part of our #AHA25 coverage: https://bit.ly/4p5NoXe #CardioSky #MedSky

CELEBRATE: Zalunfiban administered on first medical contact w/ suspected #STEMI patients was associated w/ improved patency of the infarct-related artery at index angiography and a significantly lower chance of MACE at 30 days. Read more: https://bit.ly/47N6jyH #AHA25 #CardioSky #MedSky

#AHA25: With ⬆️ BP continuing to be a 🌍 challenge, effective management must remain a global priority. The results from BETTER-BP 👇, GOFRESH & Healthy Family offer 3 strategies targeting behavior, diet & family that could inform larger-scale programs. 🔗 https://bit.ly/3XiMhr0 #CardioSky #MedSky

Hear insights from #ACCPresident Christopher M. Kramer, MD, FACC, on the groundbreaking CRISPR-Cas9 trial presented at #AHA25 and what it means for cardiovascular care. Get full details ➡️ https://bit.ly/47Nfb7O #CardioSky #MedSky #ACCAnywhere @chriskramermd.bsky.social

Does one cup a day keep #AFib away? ☕ Findings from DECAF show coffee is linked to lower recurrence after cardioversion. Follow ACC's coverage of #AHA25 for more insights ➡️ https://bit.ly/4p2s1pD #CardioSky #MedSky

DARE-AF & META-AF: Findings 🔎 on post-ablation strategies for patients w/ #AFib, including use of dapagliflozin in people w/out current indications for #SGLT2i & metformin compared w/ standard care in those w/ obesity/overweight but no #diabetes. https://bit.ly/4nJMbUc #AHA25 #CardioSky #MedSky

🎤 Your Voice, Your Session! If you could design one session for #ACC26 that isn’t in the current program, what would it be? 👂 Tell us! We’re listening! Submit now ↪️ bit.ly/4owX90K #AHA25 #CardioSky #MedSky

TOP findings from #AHA25 found a liberal transfusion strategy did not reduce death or major ischemic outcome rates compared w/ a restrictive strategy in patients at ⬆️ risk of a cardiac event following major vascular or general surgery. Get the details ➡️ https://bit.ly/4nMHXeD #CardioSky #MedSky

Studies like OCEAN from #AHA25 are reshaping strategies for managing #AFib, exploring topics like ongoing anticoagulation post-catheter ablation; optimal antithrombotic approaches after #cvPCI; and LAAC vs. medical therapy in high-risk patients. More ➡️ https://bit.ly/47vGSTD #CardioSky #MedSky

MAPLE-HCM: Patients with oHCM treated with aficamten saw superior benefits in #heartfailure symptoms, exercise capacity, LVOT gradient and overall health status when compared to metoprolol. Learn more: https://bit.ly/47wIVqD #AHA25 #JACC #HCM #cvHCM #CardioSky #MedSky @jaccjournals.bsky.social

#AHA25: ACC Vice President Roxana Mehran, MD, FACC, shares insights on groundbreaking cardiometabolic therapeutic trials, including highlights from the VESALIUS-CV study. Get the full details here: https://bit.ly/4oBNohQ #cvPrev #cvLipids #ACCAnywhere #CardioSky #MedSky

VESALIUS-CV results show evolocumab reduced the risk of first cardiovascular events among patients with atherosclerosis or diabetes and without a previous #cvMI or #stroke compared with placebo. Read more in our #AHA25 coverage: https://bit.ly/4oBNohQ #CardioSky #MedSky

CRISPR-Cas9 ➡️ First-in-Human trial presented at #AHA25 suggests one-time infusion of an investigational CRISPR-Cas9 therapy targeting ANGPTL3 is safe & can reduce both LDL cholesterol & triglycerides. Read the ACC News Story for more: https://bit.ly/47Nfb7O #cvLipids #CardioSky #MedSky

2️⃣ late-breaking science presentations highlight new treatments for severe hypertriglyceridemia at #AHA25. Read how the novel DR10624 medication reduced triglyceride levels ➕ liver fat, & about the benefits of olezarsen in ↘️ pancreatitis. 🔗 https://bit.ly/47xGfch #CardioSky #MedSky

🆕 #JACC Leadership Page from #ACCPresident @chriskramermd.bsky.social#JACC#ACCPresidentnd ACC leaders Drs. Malissa J. Wood and Sandra J. Lewis emphasize the value of intentional investment in leadership development ➕ non-clinical competencies. Read more🔗 https://bit.ly/4hRRn7e #ACCLeadership #CardioSky #MedSky

Share your late-breaking clinical research with the global cardiovascular community at #ACC26. Accepted LBCT submissions will be presented during one of seven LBCT sessions. 🗓️ Deadline: Tuesday, Nov. 18 at 1 p.m. ET. ⏰ Learn more & submit today! 👉 https://bit.ly/3JNubKG #CardioSky #MedSky

What if your genes could predict a life-threatening condition before symptoms ever appear? Explore how medical science uncovered the genetic roots of thoracic aortic aneurysm & why that discovery changed everything. Tune in to this #ACCEL Lite episode ➡️ https://bit.ly/43awVZg #CardioSky #MedSky

Interested in clinical trials research? Join a growing group of professionals addressing #cardiovascular disparities in trials while growing skills, building connections & elevating expertise! 🔎 Structural #heartdisease ➕ #cvEP tracks Apply to join ➡️ https://bit.ly/43vUtYt #EPeeps

Enhance your clinical expertise w/ 🆕 #ACCEd on #cvImaging. Modern CCTA Practice: Core Competencies & Advanced Technologies provides an overview of contemporary CCTA use, from foundational principles to cutting-edge applications. Learn more: https://bit.ly/3LolUgG #CardioSky #MedSky

Interested in being a mentor? The ACC is seeking volunteer mentors for its #ACCIMProgram ➕ Pediatric Residents Cardiology Programs. Get involved and inspire the next generation of #cardiology professionals. Learn more and apply by Dec. 10 👉 https://bit.ly/472nhdW #ACCHealthEquity #cvPed

In this #CardiaCast episode, experts explore how coronary computed tomography angiography fits into the clinical decision-making process for evaluating stable chest pain, as outlined in the latest 2021 Chest Pain Guidelines. Tune in now ➡️ https://bit.ly/48QunDb #CardioSky #MedSky

Light-to-moderate alcohol consumption may be associated w/ increases in BP & stopping drinking – even drinking less – may lead to clinically meaningful BP reductions. Read the journal scan for more ➡️ https://bit.ly/47yCMZN #JACC @jaccjournals.bsky.social

In this #CardiaCast episode, Clyde W. Yancy, MD, MSc, MACC, & Leslie L. Davis, NP, PhD, FACC, discuss the 2022 AHA/ACC/HFSA Guideline for the Management of HF & where to consider newer treatments w/ GDMT. 🎧 Tune in now: https://bit.ly/4ntgiiA #HeartFailure #CardioSky #MedSky

🆕 Concise Clinical Guidance addresses evaluation & management of #ATTRCM & provides updated strategies & best practices, taking into account expanding disease modifying therapies, #heartfailure therapies & potential future opportunities. More: 🔗 https://bit.ly/4qBQvYd #JACC #Amyloidosis #CardioSky

🚨 Last chance! 🔗 bit.ly/4hBww7V #PAsGoBeyond #PharmacistsMonth #ACCCVT

✨Upon the great pumpkin, our symbol glows, Where science leads and knowledge flows. With every spark, our Mission’s clear, To transform heart care, far and near. Innovation lights the road To better heart care around the globe.✨ 🎃 Happy Friday to the #CardioSky community!

🚨 Last chance! 📢 PAs & PharmDs: Join by Oct. 31 to get 3️⃣ free months of membership ➕ a waived application fee (Promo Code: SAVE2025). Get access to clinical tools, DocMatter, #ACCEd discounts, & more. 🔗 https://bit.ly/4hBww7V #PAsGoBeyond #PharmacistsMonth #CardioSky #MedSky

📣🫀 Hey #CardioSky Community! We're looking for ONE more #ACC26 session idea! What topics did you miss learning about in this past year? 💡Submit a 🆕topic here: https://t.co/mWvPSQCrXL Stay tuned to vote on the top three submissions soon!

ICYMI: Interventional cardiology was in the spotlight at #TCT2025! FAME 3, DOSE Trials explore cost-effectiveness, operator radiation risk after coronary procedures. 📰 Find all the insights in the ACC News story ➡️ https://bit.ly/4nzLZaf #JACC @jaccjournals.bsky.social

⏰ Just 1️⃣ day left to apply for the Using Her Voice Scholars Program! Amplify your voice, gain mentorship, and access career-boosting opportunities. Learn more and apply by Oct 31! ➡️ https://bit.ly/4qjSd0h #ACCAcademic #WomenInCardiology

Latest #JACC Leadership Page highlights ACC efforts to advocate for: 🌿Sustainable reform 💬Transparency 🛡️Protection of patient access More from #ACCPresident @ChrisKramerMD & ACC Health Affairs Committee Chair Dr. William A. Van Decker 👉 https://bit.ly/475dcwp #ACCLeadership

High-dose inactivated influenza vaccine demonstrated significantly greater effectiveness in ↘️ severe outcomes & hospitalizations compared w/ standard-dose inactivated influenza vaccine, based on findings from the FLUNITY-HD pooled analysis. 🔗 https://bit.ly/43JhaIK #cvPrev #CardioSky #MedSky

#GHE25: "#CVD claims 1 in 3 lives globally. But w/ bold vision, powerful tools & technology, we can reduce that burden. The world will see how CV societies & governments can unite to make lives healthier, longer & free from preventable #heartdisease" - Neal Kovach (ACC) #ACCIntl #CardioSky #MedSky

We’re proud to award Johns Hopkins Aramco Hospital w/ the Transcatheter Valve Certification at #GHE25 – marking a milestone in Saudi Arabia & the region. 👏 Interested in learning how your 🏥 can achieve this? Explore ➡️ https://bit.ly/47AjWl3 #NCDR #ACCAccreditation #ACCIntl

Dr. Dinesh Kalra has been named chair-elect of the ACC Board of Governors! He’ll step into the role in April 2026 and serve as BOG Chair from 2027–2028, following Dr. Renuka Jain's term as chair. Read more: https://bit.ly/4oGSzMT #ACCBOG #ACCLeadership

💡 Elevate your clinical practice at #FusterCVS by learning directly from leading experts. Discover cutting-edge CV research, evidence-based strategies, & more. Explore this year’s dynamic sessions & faculty line-up. Advance registration ends tonight at 11:59 p.m. ET! ⏰ https://bit.ly/4lfjiyL

Huge milestone for CV care in Saudi Arabia! 👏 Congratulations to Prince Sultan Cardiac Center Qassim, Saud Al Babtain Cardiac Center & Madinah Cardiac Center for earning ACC’s International Center of Excellence Award. More on ICOE awards: https://bit.ly/47AjWl3 #GHE25 #ACCIntl #CardioSky #MedSky

Four key plasma proteins associated w/ potential causal roles in blood pressure regulation and increased risk of cardiovascular events, including #cvCAD and stroke, were identified in a Mendelian randomization study. Read the journal scan for more ➡️ https://bit.ly/435QUZ3

Learn from a real cardiology malpractice case using the Three Ps: Prevent, Preclude, Prevail w/ this 🆓 webinar by The Doctors Company (0.5 AMA PRA Category 1 Credits™). Explore exclusive coverage discounts & benefits for eligible ACC members. 🔗 https://bit.ly/3WiC51y #CardioSky #ACCMember

The PhysioSync-HF trial investigates conduction system pacing as a potentially more effective & affordable alternative to traditional cardiac resynchronization therapy. Tune into #ACCEL Lite episode for more insights ➡️ https://bit.ly/4qxh6pp #CardioSky #MedSky

That's a wrap on #TCT2025! Drs. Fred Kusumoto & Martin Zenni share their top highlights from TCT 2025. Don’t miss their insights on what’s shaping the future of interventional cardiology. Catch up on ACC's full coverage of the latest science from TCT ➡️ https://bit.ly/4oIRbcO #CardioSky #MedSky

🚨 #AI-based #ECG analysis significantly improved #STEMI detection, ⬇️ false activations and enhanced recognition of non-conventional presentations, based on late-breaking science from #TCT2025 and published in #JACCINT. Read more: https://bit.ly/3LdZn6b #CardioSky #MedSky @jaccjournals.bsky.social

Late-breaking science at #TCT2025 addresses immediate #PCI guided by iFR vs. deferred PCI of nonculprit lesions in acute #STEMI patients, as well as management of patients with MINOCA. Read highlights: https://bit.ly/47J3iRg #ACCIC #CardioSky #MedSky

🆕 in #JACC from #TCT2025: STRIVE results show alteplase did not improve the composite of MACE or microvascular obstruction in patients undergoing primary #PCI for #STEMI and large thrombus burden. 💻 Read more: https://bit.ly/3La1XdA #CardioSky #MedSky @jaccjournals.bsky.social

PROCTOR trial findings from #TCT2025 show #PCI of saphenous vein grafts was associated with better 1-year clinical outcomes than PCI of native vessels in patients with prior #cvCABG presenting with graft failure. Read on: https://bit.ly/4qwEBih #JACC

🆕 #JACC Focus Issue: High BP Guideline Spotlight dives into the implementation failures that have led to #hypertension going undiagnosed, untreated & inadequately controlled in the U.S. & charts a path forward. Read more: https://bit.ly/4nCDlry #cvPrev #CardioSky #MedSky